GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $6.27 $8.02 Friday, 19th Apr 2024 ARDX stock ended at $6.48. This is 0.621% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.63% from a day low at $6.27 to a day high of $6.56.
90 days $6.27 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
2023-09-14 $4.59 $4.76 $4.57 $4.66 3 174 707
2023-09-13 $4.86 $4.97 $4.57 $4.59 4 437 421
2023-09-12 $4.77 $4.90 $4.66 $4.83 4 124 524
2023-09-11 $4.58 $4.78 $4.50 $4.73 4 937 437
2023-09-08 $4.56 $4.68 $4.44 $4.59 4 366 003
2023-09-07 $4.78 $4.80 $4.47 $4.54 10 660 836
2023-09-06 $4.64 $4.90 $4.51 $4.73 8 758 322
2023-09-05 $4.85 $4.88 $4.55 $4.59 6 671 805
2023-09-01 $4.29 $4.84 $4.21 $4.82 11 049 728
2023-08-31 $4.27 $4.29 $4.18 $4.26 4 917 541
2023-08-30 $4.19 $4.34 $4.14 $4.24 6 695 453
2023-08-29 $4.21 $4.45 $4.14 $4.20 6 506 128
2023-08-28 $3.96 $4.26 $3.95 $4.25 7 725 023
2023-08-25 $3.69 $3.98 $3.70 $3.94 10 211 738
2023-08-24 $3.67 $3.66 $3.50 $3.51 2 726 026
2023-08-23 $3.50 $3.75 $3.51 $3.67 3 350 418
2023-08-22 $3.65 $3.63 $3.48 $3.51 2 508 676
2023-08-21 $3.66 $3.70 $3.47 $3.58 3 095 275
2023-08-18 $3.46 $3.67 $3.42 $3.61 3 795 252
2023-08-17 $3.75 $3.76 $3.50 $3.51 5 093 696
2023-08-16 $3.88 $3.95 $3.71 $3.72 4 171 041
2023-08-15 $3.93 $4.00 $3.83 $3.85 3 611 663
2023-08-14 $3.97 $4.00 $3.83 $3.97 2 586 859
2023-08-11 $4.04 $4.12 $3.96 $4.01 2 394 174
2023-08-10 $3.94 $4.13 $3.90 $4.04 5 171 232
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT